306 related articles for article (PubMed ID: 34473938)
1. Physical Activity and Its Association with Traditional Outcome Measures in Pulmonary Arterial Hypertension.
Minhas J; Shou H; Hershman S; Zamanian R; Ventetuolo CE; Bull TM; Hemnes A; Chakinala MM; Mathai S; Al-Naamani N; Ellenberg S; Matura LA; Kawut SM; Shcherbina A
Ann Am Thorac Soc; 2022 Apr; 19(4):572-582. PubMed ID: 34473938
[No Abstract] [Full Text] [Related]
2. Digital Tracking of Physical Activity, Heart Rate, and Inhalation Behavior in Patients With Pulmonary Arterial Hypertension Treated With Inhaled Iloprost: Observational Study (VENTASTEP).
Stollfuss B; Richter M; Drömann D; Klose H; Schwaiblmair M; Gruenig E; Ewert R; Kirchner MC; Kleinjung F; Irrgang V; Mueller C
J Med Internet Res; 2021 Oct; 23(10):e25163. PubMed ID: 34623313
[TBL] [Abstract][Full Text] [Related]
3. Right Ventricular Function is Associated With Quality of Life in Patients With Systemic Lupus Erythematosus Associated Pulmonary Arterial Hypertension.
Wang H; Wang Q; Tian Z; Guo X; Lai J; Li M; Zhao J; Liu Y; Zeng X; Fang Q
Heart Lung Circ; 2019 Nov; 28(11):1655-1663. PubMed ID: 30301670
[TBL] [Abstract][Full Text] [Related]
4. A Mobile Health Intervention to Increase Physical Activity in Pulmonary Arterial Hypertension.
Hemnes AR; Silverman-Lloyd LG; Huang S; MacKinnon G; Annis J; Whitmore CS; Mallugari R; Oggs RN; Hekmat R; Shan R; Huynh PP; Yu C; Martin SS; Blaha MJ; Brittain EL
Chest; 2021 Sep; 160(3):1042-1052. PubMed ID: 33878341
[TBL] [Abstract][Full Text] [Related]
5. Risk classification of pulmonary arterial hypertension by echocardiographic combined assessment of pulmonary vascular resistance and right ventricular function.
Kawamukai M; Hashimoto A; Koyama M; Nagano N; Nishida J; Mochizuki A; Kouzu H; Muranaka A; Kokubu N; Nagahara D; Yuda S; Tsuchihashi K; Miura T
Heart Vessels; 2019 Nov; 34(11):1789-1800. PubMed ID: 31119378
[TBL] [Abstract][Full Text] [Related]
6. Tricuspid annular plane systolic excursion is a robust outcome measure in systemic sclerosis-associated pulmonary arterial hypertension.
Mathai SC; Sibley CT; Forfia PR; Mudd JO; Fisher MR; Tedford RJ; Lechtzin N; Boyce D; Hummers LK; Housten T; Zaiman AL; Girgis RE; Hassoun PM
J Rheumatol; 2011 Nov; 38(11):2410-8. PubMed ID: 21965638
[TBL] [Abstract][Full Text] [Related]
7. Correlation Between Right Ventricular Echocardiography Measurements and Functional Capacity in Patients With Pulmonary Arterial Hypertension.
Woo JL; DiLorenzo MP; Rosenzweig E; Pasumarti N; Villeda GV; Berman-Rosenzweig E; Krishnan U
Tex Heart Inst J; 2022 Nov; 49(6):. PubMed ID: 36350291
[TBL] [Abstract][Full Text] [Related]
8. Counting Steps: A New Way to Monitor Patients with Pulmonary Arterial Hypertension.
Sehgal S; Chowdhury A; Rabih F; Gadre A; Park MM; Li M; Wang X; Highland KB;
Lung; 2019 Aug; 197(4):501-508. PubMed ID: 31144016
[TBL] [Abstract][Full Text] [Related]
9. Echocardiographic Assessment of Right Ventricular Function and Response to Therapy in Pulmonary Arterial Hypertension.
Shelburne NJ; Parikh KS; Chiswell K; Shaw LK; Sivak J; Arges K; Tomfohr J; Velazquez EJ; Kisslo J; Samad Z; Rajagopal S
Am J Cardiol; 2019 Oct; 124(8):1298-1304. PubMed ID: 31481176
[TBL] [Abstract][Full Text] [Related]
10. Electrocardiographic Abnormalities and Their Association with Outcomes in Randomized Clinical Trials of Pulmonary Arterial Hypertension.
Minhas J; Moutchia J; Al-Naamani N; Mazurek JA; Holmes JH; Appleby D; Smith KA; Fritz JS; Pugliese SC; Palevsky HI; Kawut SM
Ann Am Thorac Soc; 2024 Jun; 21(6):858-865. PubMed ID: 38241602
[No Abstract] [Full Text] [Related]
11. Anastrozole in Pulmonary Arterial Hypertension. A Randomized, Double-Blind, Placebo-controlled Trial.
Kawut SM; Archer-Chicko CL; DeMichele A; Fritz JS; Klinger JR; Ky B; Palevsky HI; Palmisciano AJ; Patel M; Pinder D; Propert KJ; Smith KA; Stanczyk F; Tracy R; Vaidya A; Whittenhall ME; Ventetuolo CE
Am J Respir Crit Care Med; 2017 Feb; 195(3):360-368. PubMed ID: 27602993
[TBL] [Abstract][Full Text] [Related]
12. Interest of TAPSE/sPAP ratio for noninvasive pulmonary arterial hypertension risk assessment.
Fauvel C; Raitiere O; Boucly A; De Groote P; Renard S; Bertona J; Lamblin N; Artaud-Macari E; Viacroze C; Schleifer D; Dominique S; Pichon J; Jais X; Montani D; Sitbon O; Savale L; Humbert M; Bauer F
J Heart Lung Transplant; 2022 Dec; 41(12):1761-1772. PubMed ID: 36202691
[TBL] [Abstract][Full Text] [Related]
13. Follow-up tricuspid annular plane systolic excursion predicts survival in pulmonary arterial hypertension.
Mazurek JA; Vaidya A; Mathai SC; Roberts JD; Forfia PR
Pulm Circ; 2017; 7(2):361-371. PubMed ID: 28597759
[TBL] [Abstract][Full Text] [Related]
14. Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry.
Kolaitis NA; Zamanian RT; de Jesus Perez VA; Badesch DB; Benza RL; Burger CD; Chakinala MM; Elwing JM; Feldman J; Lammi MR; Mathai SC; McConnell JW; Presberg KW; Robinson JC; Sager J; Shlobin OA; Simon MA; Kawut SM; Glidden DV; Singer JP; De Marco T;
Ann Am Thorac Soc; 2021 Apr; 18(4):613-622. PubMed ID: 33064950
[No Abstract] [Full Text] [Related]
15. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
16. Symptom phenotypes in pulmonary arterial hypertension: The PAH "symptome".
Matura LA; Fargo JD; Boyle K; Fritz JS; Smith KA; Mazurek JA; Pinder D; Archer-Chicko CL; Palevsky HI; Pack AI; Sommers MS; Kawut SM
Pulm Circ; 2022 Jul; 12(3):e12135. PubMed ID: 36186717
[TBL] [Abstract][Full Text] [Related]
17. EmPHasis-10 health-related quality of life score predicts outcomes in patients with idiopathic and connective tissue disease-associated pulmonary arterial hypertension: results from a UK multicentre study.
Lewis RA; Armstrong I; Bergbaum C; Brewis MJ; Cannon J; Charalampopoulos A; Church AC; Coghlan JG; Davies RJ; Dimopoulos K; Elliot C; Gibbs JSR; Gin-Sing W; Haji G; Hameed AG; Howard LS; Johnson MK; Kempny A; Kiely DG; Lo Giudice F; McCabe C; Peacock AJ; Peleyeju O; Pepke-Zaba J; Polwarth G; Price L; Sabroe I; Schreiber BE; Sheares K; Taboada D; Thompson AAR; Toshner MR; Wanjiku I; Wort SJ; Yorke J; Condliffe R
Eur Respir J; 2021 Feb; 57(2):. PubMed ID: 32631835
[TBL] [Abstract][Full Text] [Related]
18. [Value of four-dimensional echocardiography combined with speckle tracking technique on the assessment of right heart function and prognosis in patients with pulmonary arterial hypertension].
Zhang XM; Zhuang Q; Yang MH; Wang W; Zheng Y; Qiao ZQ; Shen JY; Shen XD
Zhonghua Xin Xue Guan Bing Za Zhi; 2018 Dec; 46(12):965-971. PubMed ID: 30572401
[No Abstract] [Full Text] [Related]
19. Right ventricular function and its coupling to pulmonary circulation predicts exercise tolerance in systolic heart failure.
Legris V; Thibault B; Dupuis J; White M; Asgar AW; Fortier A; Pitre C; Bouabdallaoui N; Henri C; O'Meara E; Ducharme A;
ESC Heart Fail; 2022 Feb; 9(1):450-464. PubMed ID: 34953062
[TBL] [Abstract][Full Text] [Related]
20. Predictive value of non-invasive right ventricle to pulmonary circulation coupling in systemic lupus erythematosus patients with pulmonary arterial hypertension.
Guo X; Lai J; Wang H; Tian Z; Wang Q; Zhao J; Li M; Fang Q; Fang L; Liu Y; Zeng X
Eur Heart J Cardiovasc Imaging; 2021 Jan; 22(1):111-118. PubMed ID: 31872222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
